Cesarean Birth, Phenylephrine
Conditions
Keywords
Phenylephrine, Oxytocin induced hypotension
Brief summary
Cesarean section is one of the commonly performed surgical procedures in the world. Once baby is delivered during the surgical procedure anesthesiologist administer Oxytocin drug through IV cannula which helps the Uterus to contract so that excessive blood loss doesnt occur. But this is associated with fall in blood pressure frequently requiring administration of medications to treat low blood pressure. The most frequently used drug is phenylephrine which can administered along with oxytocin to prevent fall in blood pressure. This study will compare to different doses of Phenylephrine to prevent fall in blood pressure.
Detailed description
Cesarean section is one of the most commonly performed surgical procedures worldwide. Following delivery of the neonate, oxytocin is routinely administered intravenously to promote uterine contraction and thereby reduce the risk of postpartum hemorrhage. However, oxytocin administration is frequently associated with maternal hypotension, which may necessitate pharmacological intervention. Phenylephrine, a selective α-adrenergic agonist, is commonly used to prevent or treat oxytocin-induced hypotension due to its vasoconstrictive properties. The optimal prophylactic dose of phenylephrine administered concurrently with oxytocin remains uncertain. This study aims to compare two different doses of phenylephrine for the prevention of hypotension following oxytocin administration during cesarean section.
Interventions
After delivery of Baby during C section, patient will be administered 3 IU of Oxytocin over 3 minutes along with 75 micrograms of Phenylephrine Intravenously.
After delivery of Baby during C section, patient will be administered 3 IU of Oxytocin over 3 minutes along with 50 micrograms of Phenylephrine Intravenously.
Sponsors
Study design
Eligibility
Inclusion criteria
\- Females having a singleton pregnancy Patients planned for elective cesarean section under spinal anesthesia
Exclusion criteria
* Patients having a placental abnormality * Patients taking beta-blocker and vasodilator therapy * Patients with hypertensive disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Hypotensive episodes | Number of hypotensive episodes occuring upto 10 minutes after administration of Oxytocin and Phenylephrine | Hypotension will be defined as fall in Mean Arterial pressure by more than 20% from baseline value. |
Secondary
| Measure | Time frame |
|---|---|
| Rescue Phenylephrine consumed | This will be the total amount of Phenylephrine consumed to treat the hypotensive episodes occuring upto 10 minutes after administration of Oxytocin and Phenylephrine |
Countries
Pakistan
Contacts
Head of Department of Anesthesia